Clinical Trial Update: Efficacy and Safety of Enstilar Foam in Combination With Apremilast (Otezla) in Patients With Moderate Plaque Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the efficacy and safety of Enstilar Foam in combination with Apremilast (Otezla) for moderate plaque psoriasis; study completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Apremilast (apremilast)
• Enstilar Foam

Snippet

Sponsor: L.H. Kircik, M.D. | Conditions: Plaque Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2019-03-13